Haixin Group (Stock code: 600851.SH) subsidiary's Vitamin B6 injection passed the generic drug consistency evaluation.

Zhitong Finance APP News, Haixin Shares (600851.SH) announced that its subsidiary, Jiangxi Gannan Haixin Pharmaceutical Co., Ltd. (referred to as Gannan Haixin), recently obtained the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for the chemical drug "Vitamin B6 Injection". This drug has undergone evaluation for consistency in quality and efficacy as a generic drug.